{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:45:24Z","timestamp":1786715124221,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0253-7613.190765","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T08:18:14Z","timestamp":1474273094000},"page":"604","source":"Crossref","is-referenced-by-count":3,"title":["Eperisone hydrochloride-induced maculopapular rash"],"prefix":"10.4103","volume":"48","author":[{"given":"Aruna","family":"Bhushan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Balaraddiyavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BasavarajC","family":"Kotinatot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouramma","family":"Huggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.190765-1","first-page":"209","volume-title":"The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial","author":"Bose","year":"1999","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"key-10.4103\/0253-7613.190765-2","first-page":"271","volume-title":"Mechanisms of action of eperisone on isolated dog saphenous arteries and veins","author":"Inoue","year":"1989","journal-title":"Jpn J Pharmacol"},{"key":"key-10.4103\/0253-7613.190765-3","first-page":"150","volume-title":"Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone","author":"Yang","year":"2004","journal-title":"Pharmacology"},{"key":"key-10.4103\/0253-7613.190765-4","first-page":"757","volume-title":"Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery","author":"Fujioka","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0253-7613.190765-5","first-page":"709","volume-title":"A case of eperisone hydrochloride (Myonal) - Induced drug eruption leading to erythema and angioedema","author":"Ueno","year":"2007","journal-title":"Arerugi"},{"key":"key-10.4103\/0253-7613.190765-6","first-page":"239","volume-title":"A method for estimating the probability of adverse drug reactions","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0253-7613.190765-7","first-page":"2229","volume-title":"Preventability and severity assessment in reporting adverse drug reactions","author":"Hartwig","year":"1992","journal-title":"Am J Hosp Pharm"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:25:19Z","timestamp":1786713919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.190765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"alternative-id":["190765"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.190765","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}